All Updates

Today, lawmakers voted to reauthorize Medicaid expansion in New Hampshire, ensuring thousands of Granite Staters have access to the affordable healthcare they need. The vote is particularly poignant for the dozens of cancer patients and survivors who lobbied for passage of this legislation as June marks Cancer Survivors Month.

Today, Gov. Kevin Stitt signed legislation that will improve access to care for cancer patients by expanding coverage for biomarker testing. Senate Bill 513 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.

Today, the U.S. House of Representatives and the U.S. Senate introduced the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act, a bill which would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2028. For more than 30 years, the NBCCEDP has effectively provided critical breast and cervical cancer screenings, follow-up, diagnosis and treatment to lower income, uninsured and underinsured women.

Today, the U.S. House of Representatives and the U.S. Senate introduced the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) for Cancer Act, a bill which would reauthorize the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) through 2028. For more than 30 years, the NBCCEDP has effectively provided critical breast and cervical cancer screenings, follow-up, diagnosis and treatment to lower income, uninsured and underinsured women.

LAS VEGAS, NEV. – The Nevada State Legislature passed Assembly Bill 155 as the 82nd legislative session adjourned, Monday. The bill establishes provisions for biomarker testing in Nevada but falls short of ensuring broader patient access to needed testing. While the American Cancer Society Cancer Action Network (ACS CAN) appreciates lawmakers’ recognition of the growing importance of biomarker testing in the treatment of cancer and other conditions, this bill was significantly weakened from its original intent.

ALBANY, NY – JUNE 5, 2023 – This afternoon, the New York State Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. This legislative victory came several hours after the American Cancer Society Cancer Action Network (ACS CAN) hosted

ALBANY, NY – JUNE 5, 2023 – This afternoon, the New York State Senate passed legislation that would ensure biomarker testing is covered by more insurance plans, including Medicaid, when patients need it. This legislative victory came several hours after the American Cancer Society Cancer Action Network (ACS CAN) hosted

Gov. Greg Abbott signed legislation that will improve access to care for cancer patients and people with other conditions by expanding coverage for biomarker testing. Senate Bill 989 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.

Gov. Greg Abbott signed legislation that will improve access to care for cancer patients and people with other conditions by expanding coverage for biomarker testing. Senate Bill 989 will enable more patients to benefit from biomarker testing, an essential step in accessing precision medicine treatments.